Punch & Associates Investment Management Inc. Takes Position in Addus HomeCare Corporation $ADUS

Punch & Associates Investment Management Inc. purchased a new stake in shares of Addus HomeCare Corporation (NASDAQ:ADUSFree Report) during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 208,135 shares of the company’s stock, valued at approximately $20,911,000. Addus HomeCare makes up approximately 1.0% of Punch & Associates Investment Management Inc.’s investment portfolio, making the stock its 28th biggest position.

A number of other institutional investors have also added to or reduced their stakes in ADUS. Global Retirement Partners LLC boosted its holdings in shares of Addus HomeCare by 395.7% during the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock valued at $25,000 after buying an additional 186 shares in the last quarter. Larson Financial Group LLC increased its stake in shares of Addus HomeCare by 133.3% in the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock worth $28,000 after acquiring an additional 136 shares in the last quarter. NFJ Investment Group LLC bought a new position in shares of Addus HomeCare in the 2nd quarter worth about $29,000. Acumen Wealth Advisors LLC purchased a new position in Addus HomeCare during the 4th quarter valued at about $29,000. Finally, Arax Advisory Partners lifted its position in Addus HomeCare by 95.8% during the 4th quarter. Arax Advisory Partners now owns 280 shares of the company’s stock valued at $30,000 after acquiring an additional 137 shares during the period. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Price Performance

Shares of NASDAQ ADUS opened at $120.71 on Thursday. The firm has a market cap of $2.25 billion, a P/E ratio of 21.18, a PEG ratio of 1.62 and a beta of 0.87. Addus HomeCare Corporation has a twelve month low of $87.95 and a twelve month high of $124.43. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.05. The company has a 50 day moving average of $111.05 and a 200 day moving average of $102.79.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last issued its earnings results on Monday, August 3rd. The company reported $1.73 EPS for the quarter, beating the consensus estimate of $1.70 by $0.03. The business had revenue of $377.41 million for the quarter, compared to the consensus estimate of $376.24 million. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%.The company’s revenue was up 8.0% compared to the same quarter last year. During the same period last year, the business posted $1.49 EPS. As a group, research analysts expect that Addus HomeCare Corporation will post 6.3 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on ADUS. Citigroup restated a “market outperform” rating on shares of Addus HomeCare in a report on Friday, July 24th. Barclays boosted their price target on Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a research report on Wednesday, July 8th. Weiss Ratings upgraded Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. Royal Bank Of Canada raised their price objective on Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th. Finally, Citizens Jmp reiterated a “market outperform” rating and set a $142.00 price objective on shares of Addus HomeCare in a research note on Monday, May 18th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $130.88.

Check Out Our Latest Stock Analysis on Addus HomeCare

Insider Activity at Addus HomeCare

In related news, insider Heather Brianne Dixon sold 288 shares of the stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total transaction of $27,005.76. Following the sale, the insider directly owned 44,371 shares of the company’s stock, valued at $4,160,668.67. This trade represents a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.10% of the stock is owned by company insiders.

About Addus HomeCare

(Free Report)

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Further Reading

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUSFree Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.